These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis. Wan Q; Tang J; Han Y; Wang D; Ye H Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239 [TBL] [Abstract][Full Text] [Related]
5. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis. Liu FY; Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus. Malhotra C; Singh H; Jain AK; Gupta A; Ram J Ocul Immunol Inflamm; 2022 Jul; 30(5):1083-1091. PubMed ID: 33764241 [TBL] [Abstract][Full Text] [Related]
17. Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial. Müller EG; Santos MSD; Freitas D; Gomes JÁP; Belfort R Arq Bras Oftalmol; 2017 Jun; 80(3):154-158. PubMed ID: 28832739 [TBL] [Abstract][Full Text] [Related]
18. A comparative study between ciclosporine A eye drop (2%) and tacrolimus eye ointment (0.03%) in management of children with refractory vernal keratoconjunctivitis. Heikal MA; Soliman TT; Abousaif WS; Shebl AA Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):353-361. PubMed ID: 34453603 [TBL] [Abstract][Full Text] [Related]
19. Monotherapy of topical tacrolimus 0.03% in the treatment of vernal keratoconjunctivitis in the pediatric population. Samyukta SK; Pawar N; Ravindran M; Allapitchai F; Rengappa R J AAPOS; 2019 Feb; 23(1):36.e1-36.e5. PubMed ID: 30664932 [TBL] [Abstract][Full Text] [Related]
20. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]